Medicover revenue and financials
kr 261.50Change from previous close: +0.58%Absolute change: +kr 1.50
In the fiscal year ended December 2025, Medicover reported revenue of €2.38B (+13.69% year over year). Net income was €77.5M, a net margin of 3.3%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +13.69%
- 2025 vs 2024
- Net income growth
- +364.07%
- 2025 vs 2024
- Net margin
- 3.3%
- 2024: 0.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 344 | 262 | 205 | 170 | — |
| Depreciation and amortization | 215 | 198 | 183 | 162 | — |
| Capital expenditure | -158 | -122 | -111 | -141 | — |
| Investing cash flow | -322 | -135 | -120 | -185 | — |
| Financing cash flow | -5.8 | -108 | -73.7 | -24.3 | — |
| Dividends paid | -22.5 | -18.0 | -17.9 | -17.8 | — |
| Share repurchases | — | 0.0 | -0.3 | 0.0 | -0.3 |
| Debt issued | 945 | 885 | 462 | 524 | — |
| Debt repaid | -775 | -755 | -397 | -435 | — |
| Effect of exchange rates | -3.3 | -0.2 | -1.1 | -2.6 | — |
| Net change in cash | 15.8 | 19.2 | 11.5 | -38.9 | — |
| Free cash flow | 186 | 140 | 94.5 | 29.6 | — |